Overweightness
📧 Sign up to get email alerts when something new happens for Overweightness.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2022-10-28EMA confirms recommendation to withdraw marketing authorisations for amfepramone medicines
EMA confirms a recommendation to withdraw marketing authorisations for amfepramone medicines used for weight loss due to safety concerns.